TRU-015 Terminated Phase 2 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00634933Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis